Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mandatory treatment for methamphetamine use in Australia.
Coleman M, Ridley K, Christmass M. Coleman M, et al. Among authors: christmass m. Subst Abuse Treat Prev Policy. 2021 Apr 9;16(1):33. doi: 10.1186/s13011-021-00370-1. Subst Abuse Treat Prev Policy. 2021. PMID: 33836785 Free PMC article. Review.
A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia.
Siefried KJ, Ezard N, Christmass M, Haber P, Ali R; NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group. Siefried KJ, et al. Among authors: christmass m. Drug Alcohol Rev. 2022 Feb;41(2):309-319. doi: 10.1111/dar.13350. Epub 2021 Jul 8. Drug Alcohol Rev. 2022. PMID: 34237176 Free PMC article.
The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia.
Clay S, Wilkinson Z, Ginley M, Arunogiri S, Christmass M, Membrey D, MacCartney P, Sutherland R, Colledge-Frisby S, Marshall AD, Nagle J, Degenhardt L, Farrell M, McKetin R. Clay S, et al. Among authors: christmass m. Drug Alcohol Rev. 2024 May 5. doi: 10.1111/dar.13853. Online ahead of print. Drug Alcohol Rev. 2024. PMID: 38704742
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A, Valerio H, Peacock A, Degenhardt L, Hayllar J, Harrod ME, Henderson C, Read P, Gilliver R, Christmass M, Dunlop A, Montebello M, Whitton G, Reid D, Lam T, Alavi M, Silk D, Marshall AD, Treloar C, Dore GJ, Grebely J; ETHOS Engage Study Group. Conway A, et al. Among authors: christmass m. Int J Drug Policy. 2021 Oct;96:103421. doi: 10.1016/j.drugpo.2021.103421. Epub 2021 Aug 25. Int J Drug Policy. 2021. PMID: 34452808
Perspectives and sentiments on contingency management from people who use methamphetamine.
Clay S, Wilkinson Z, Ginley M, Arunogiri S, Christmass M, Membrey D, MacCartney P, Sutherland R, Colledge-Frisby S, Marshall AD, Nagle J, Degenhardt L, Farrell M, McKetin R. Clay S, et al. Among authors: christmass m. Drug Alcohol Rev. 2023 Sep;42(6):1427-1437. doi: 10.1111/dar.13691. Epub 2023 May 29. Drug Alcohol Rev. 2023. PMID: 37248676
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment.
Marshall AD, Conway A, Cunningham EB, Valerio H, Silk D, Alavi M, Wade A, Lam T, Zohrab K, Dunlop A, Connelly C, Christmass M, Cock V, Burns C, Henderson C, Wiseman V, Dore GJ, Grebely J. Marshall AD, et al. Among authors: christmass m. Drug Alcohol Depend. 2022 Jun 1;235:109438. doi: 10.1016/j.drugalcdep.2022.109438. Epub 2022 Apr 4. Drug Alcohol Depend. 2022. PMID: 35430521 Clinical Trial.
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
Valerio H, Alavi M, Conway A, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Among authors: christmass m. Int J Drug Policy. 2022 Jul;105:103706. doi: 10.1016/j.drugpo.2022.103706. Epub 2022 May 6. Int J Drug Policy. 2022. PMID: 35533635
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.
Valerio H, Conway A, Alavi M, Treloar C, Silk D, Murray C, Henderson C, Amin J, Read P, Degenhardt L, Christmass M, Montebello M, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Among authors: christmass m. Int J Drug Policy. 2022 Dec;110:103876. doi: 10.1016/j.drugpo.2022.103876. Epub 2022 Oct 12. Int J Drug Policy. 2022. PMID: 36240657
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
Conway A, Valerio H, Alavi M, Silk D, Treloar C, Hajarizadeh B, Marshall AD, Martinello M, Milat A, Dunlop A, Murray C, Prain B, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Christmass M, Wade A, Montebello M, Dore GJ, Grebely J; ETHOS Engage Study Group. Conway A, et al. Among authors: christmass m. Viruses. 2022 Jul 16;14(7):1555. doi: 10.3390/v14071555. Viruses. 2022. PMID: 35891535 Free PMC article.
23 results